Author details

Full Name

Stephan Wolf

Affiliation

ORCID

Career Start Year

1998

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37679568	Persister cell phenotypes contribute to poor patient outcomes after neoadjuvant chemotherapy in PDAC.	Nat Cancer	2023
34535758	Phylogeographic reconstruction of the marbled crayfish origin.	Communications Biology	2021
34112699	Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers.	Cancer Discov	2021
34036222	CATCH: A Prospective Precision Oncology Trial in Metastatic Breast Cancer.	JCO Precis Oncol	2021
33929593	Rare germline variants in the E-cadherin gene CDH1 are associated with the risk of brain tumors of neuroepithelial and epithelial origin.	Acta Neuropathol	2021
34373263	The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets.	Cancer Discov	2021
30967556	Defective homologous recombination DNA repair as therapeutic target in advanced chordoma.	Nat Commun	2019
31802000	The molecular landscape of ETMR at diagnosis and relapse.	Nature	2019
30595504	Comprehensive Analysis of Chromatin States in Atypical Teratoid/Rhabdoid Tumor Identifies Diverging Roles for SWI/SNF and Polycomb in Gene Regulation.	Cancer Cell	2019
29321523	Integrative genomic and transcriptomic analysis of leiomyosarcoma.	Nat Commun	2018
35135162	Validating Comprehensive Next-Generation Sequencing Results for Precision Oncology: The NCT/DKTK Molecularly Aided Stratification for Tumor Eradication Research Experience.	JCO Precis Oncol	2018
29489754	The landscape of genomic alterations across childhood cancers.	Nature	2018
29224141	Tagmentation-Based Library Preparation for Low DNA Input Whole Genome Bisulfite Sequencing.	Methods Mol Biol	2018
29330206	Evolution of Cytogenetically Normal Acute Myeloid Leukemia During Therapy and Relapse: An Exome Sequencing Study of 50 Patients.	Clin Cancer Res	2018
27535980	Targeting Fibroblast Growth Factor Receptor 1 for Treatment of Soft-Tissue Sarcoma.	Clin Cancer Res	2017
28597939	Precision oncology based on omics data: The NCT Heidelberg experience.	Int J Cancer	2017
28726821	The whole-genome landscape of medulloblastoma subtypes.	Nature	2017
28813413	Polylox barcoding reveals haematopoietic stem cell fates realized in vivo.	Nature	2017
27687311	Mutant KIT as imatinib-sensitive target in metastatic sinonasal carcinoma.	Ann Oncol	2017
27658714	Braf Mutations Initiate the Development of Rat Gliomas Induced by Postnatal Exposure to N-Ethyl-N-Nitrosourea.	Am J Pathol	2016
27252013	ZBTB7A mutations in acute myeloid leukaemia with t(8;21) translocation.	Nat Commun	2016
26919435	New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.	Cell	2016
27479119	Next-generation personalised medicine for high-risk paediatric cancer patients - The INFORM pilot study.	Eur J Cancer	2016
27900363	Integration of genomics and histology revises diagnosis and enables effective therapy of refractory cancer of unknown primary with <i>PDL1</i> amplification.	Cold Spring Harb Mol Case Stud	2016
24651015	Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition.	Cancer Cell	2014
25043047	Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma.	Nature	2014
24901561	Reply to: NGS library preparation may generate artifactual integration sites of AAV vectors.	Nat Med	2014
24847876	Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing.	Nature	2014
25008767	Whole exome sequencing reveals that the majority of schwannomatosis cases remain unexplained after excluding SMARCB1 and LZTR1 germline variants.	Acta Neuropathol	2014
24139898	Hypermutation of the inactive X chromosome is a frequent event in cancer.	Cell	2013
23776689	Coverage bias and sensitivity of variant calling for four whole-genome sequencing technologies.	PLoS One	2013
23824673	Multiplex Identification of Human Papillomavirus 16 DNA Integration Sites in Cervical Carcinomas.	PLoS One	2013
23770691	A largely random AAV integration profile after LPLD gene therapy.	Nat Med	2013
23817572	Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma.	Nat Genet	2013
24071908	Tagmentation-based whole-genome bisulfite sequencing.	Nat Protoc	2013
22976956	Commonly altered genomic regions in acute myeloid leukemia are enriched for somatic mutations involved in chromatin remodeling and splicing.	Blood	2012
22832583	Dissecting the genomic complexity underlying medulloblastoma.	Nature	2012
20671722	Genome-wide high-throughput integrome analyses by nrLAM-PCR and next-generation sequencing.	Nat Protoc	2010
21072239	The honey bee epigenomes: differential methylation of brain DNA in queens and workers.	PLoS Biol	2010
19347735	Chronic lymphocytic leukemia and 13q14: miRs and more.	Leukemia and Lymphoma	2009
16217763	Ala228 variant of trail receptor 1 affecting the ligand binding site is associated with chronic lymphocytic leukemia, mantle cell lymphoma, prostate cancer, head and neck squamous cell carcinoma and bladder cancer.	Int J Cancer	2006
16684883	Allelic silencing at the tumor-suppressor locus 13q14.3 suggests an epigenetic tumor-suppressor mechanism.	Proc Natl Acad Sci U S A	2006
12010815	Down-regulation of candidate tumor suppressor genes within chromosome band 13q14.3 is independent of the DNA methylation pattern in B-cell chronic lymphocytic leukemia.	Blood	2002
11406609	B-cell neoplasia associated gene with multiple splicing (BCMS): the candidate B-CLL gene on 13q14 comprises more than 560 kb covering all critical regions.	Hum Mol Genet	2001
10797366	Relapsing nasal glioma in a three-week-old infant.		2000
11069033	Heterogeneity of the API2-MALT1 gene rearrangement in MALT-type lymphoma.	Leukemia	2000
11072235	BCMSUN, a candidate gene for B-cell chronic lymphocytic leukemia and mantle-cell lymphoma, has an independently expressed homolog on 1p22-p31, BCMSUN-like.	Int J Cancer	2000
9583687	Expressed sequences as candidates for a novel tumor suppressor gene at band 13q14 in B-cell chronic lymphocytic leukemia and mantle cell lymphoma.	Oncogene	1998